Capital Formation
April 9, 2012
|
April 9, 2012
|
April 9, 2012
|
March 6, 2012
|
Key Documents
Letters, Testimony & Comments
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
April 7 2011
Hearing Testimony
Scott Koenig, M.D., PH.D.
Before the House of Representatives Committee on Small Business
Good morning Chairman...
August 3 2010
BIO advocated for the recently enacted new Therapeutic Discovery Project Credit program, which was created as a unique opportunity for...
Press Releases
April 5 2012
Washington, D.C. (April 5, 2012) – The Biotechnology Industry Organization expressed strong support for the...
March 22 2012
Washington, DC (March 22, 2012) – The Biotechnology Industry Organization (BIO) applauds the Senate...
December 6 2011
Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO) announces program topics...
November 16 2011
Self-Funding Program Supported by Leading Biotech Trade Associations
WASHINGTON, D.C. (November 16, 2011)...
November 2 2011
Washington, DC (November 2, 2011) – The Biotechnology Industry Organization (BIO) strongly supports the Small...
Receive our newsletter from BIOtechNow
Business Solutions Sponsor
